BA
The Boeing Company
BA has the edge over CMRE overall, supported by stronger fundamentals and stronger valuation.
CMRE
Costamare Inc.
CMRE trails on the overall score without a compensating advantage in the available component scores.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
CMRE Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Strong | |
| Weak | |
| Stable |
CMRE's profitability is currently strong, and its balance sheet is stable, but its revenue and cash flow are under pressure.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA has the edge over CMRE in the historical PE scenario, which offers more potential upside but is not a forecast.
CMRE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 2.6x | $6.65 | -50% |
| Fair | 4.9x | $12.61 | -4.8% |
| Current | 5.1x | $13.24 | — |
| Forward | 5.4x | $13.24 | — |
| Expensive | 6.5x | $16.77 | +27% |
Historical ranges are pointers, not guarantees.
CMRE's PE is in its fair range at 5.1x. On analysts' estimates for next year's earnings, today's price would be 5.4x.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
BA has the edge over CMRE on the outlook, with more favorable earnings and profitability expectations.
CMRE Forward outlook
| Metric | Outlook |
|---|---|
| Deteriorating | |
| Stable | |
| Growth | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect CMRE's revenue to grow, but its profitability to weaken.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has returned to profit: it earned $9.66 per share over the past year, after losing money the year before.
CMRE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.45 | -5.4% |
| Q3 2026 | $2.59 | +3.6% |
| Q2 2026 | $2.63 | +11% |
| Q1 2026 | $2.68 | +9.8% |
| Q4 2025 | $2.85 | +17% |
| Q3 2025 | $2.50 | -17% |
| Q2 2025 | $2.36 | -16% |
| Q1 2025 | $2.44 | -5.1% |
| Q4 2024 | $2.44 | -17% |
CMRE's earnings per share have fallen from their peak: $2.59 over the past year, against $4.50 in early 2023.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA has the edge over CMRE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
CMRE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $212.1M | -5.8% |
| Q2 2026 | $200.8M | -4.8% |
| Q1 2026 | $201.6M | -55% |
| Q4 2025 | $212M | -61% |
| Q3 2025 | $225.2M | -59% |
| Q2 2025 | $210.9M | -3.2% |
| Q1 2025 | $446.2M | -6.1% |
| Q4 2024 | $548.4M | +11% |
CMRE's revenue has slid since its 2024 peak: $212M last quarter, down 5.8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 43% | -9 points |
| Q2 2026 | 45% | -5 points |
| Q1 2026 | 44% | +20 points |
| Q4 2025 | 48% | +24 points |
| Q3 2025 | 52% | +33 points |
| Q2 2025 | 50% | -4.3 points |
| Q1 2025 | 24% | +2.4 points |
| Q4 2024 | 23% | +1.7 points |
CMRE has the edge over BA on profitability, with a higher operating margin.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over CMRE on cash generation, producing positive trailing cash flow while its opponent burns cash.
CMRE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$255.9M | -187% |
| Q1 2026 | $25.5M | -81% |
| Q4 2025 | $66.2M | +174% |
| Q3 2025 | $30.9M | -52% |
| Q2 2025 | $295M | +$295.5M |
| Q1 2025 | $137.3M | +47% |
| Q4 2024 | $24.1M | +$90.5M |
| Q3 2024 | $64.9M | +$144.3M |
CMRE's free cash flow was −$133M over the past year, against $521M the year before.
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has 793M diluted shares, up 4.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
CMRE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +1.7K shares |
| 1 year | +0.4% | +468K shares |
| 3 years | -0.6% | -699K shares |
| 5 years | -2.1% | -2.6M shares |
| Available history | +1.7% | +2M shares |
CMRE has the edge over BA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
CMRE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.2x | Moderate |
| Q2 2026 | 2.1x | Moderate |
| Q1 2026 | 1.6x | Healthy |
| Q4 2025 | 1.7x | Healthy |
| Q3 2025 | 1.9x | Healthy |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 2.6x | Moderate |
| Q4 2024 | 2.8x | Moderate |
CMRE has the edge over BA on leverage, with a lower net debt burden relative to earnings.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
CMRE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.5 | Neutral |
| Stochastic | 16.2 | Oversold |
CMRE's weekly RSI is 39 (neutral) and its Stochastic is 16 (oversold).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA is trading at 18x earnings, a 26% discount to the Industrials sector's median of 24x, though its earnings don't support one.
CMRE PE vs Industrials Sector
| Metric | CMRE | Sector median | Relative |
|---|---|---|---|
| PE | 5.1x | 24x | 79% below |
| PE % | 54 | 58 | 4 pts below |
CMRE has the edge over BA on valuation relative to its sector.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
CMRE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $14.2 | 6.4% below |
| 20 week MA | $14.8 | 10% below |
| 50 week MA | $15.7 | 16% below |
| 100 week MA | $13.3 | 0.4% below |
| 200 week MA | $12.4 | 6.9% above |
CMRE has the edge over BA on trend strength, trading above more of its moving averages.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has finished lower in four of the last six years. It's down 21% so far in 2026.
CMRE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.59 | $7.84 | -18% |
| 2021 | $7.84 | $12.2 | +56% |
| 2022 | $12.2 | $9.06 | -26% |
| 2023 | $9.06 | $10.4 | +15% |
| 2024 | $10.4 | $12.8 | +23% |
| 2025 | $12.8 | $15.7 | +23% |
| 2026 YTD | $15.7 | $13.2 | -16% |
CMRE has the edge over BA on returns for 2026, with the stronger performance.